Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial

Objective To determine whether the immunogenicity of a single dose infant priming schedule of serogroup C meningococcal (MenC) conjugate vaccine is non-inferior to a two dose priming schedule when followed by a booster dose at age 12 months. Design Phase IV open label randomised controlled trial car...

Descripción completa

Detalles Bibliográficos
Autores principales: Pace, David, Khatami, Ameneh, McKenna, Jennifer, Campbell, Danielle, Attard-Montalto, Simon, Birks, Jacqueline, Voysey, Merryn, White, Catherine, Finn, Adam, Macloed, Emma, Faust, Saul N, Kent, Alison Louise, Heath, Paul T, Borrow, Ray, Snape, Matthew D, Pollard, Andrew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382115/
https://www.ncbi.nlm.nih.gov/pubmed/25832102
http://dx.doi.org/10.1136/bmj.h1554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382115/
https://www.ncbi.nlm.nih.gov/pubmed/25832102
http://dx.doi.org/10.1136/bmj.h1554

Ejemplares similares